Craft

Vimian Group

Stock Price

KR45.3

2024-10-29

Market Capitalization

KR23.7 B

2024-10-29

Revenue

€425 M

FY, 2025

Vimian Group Summary

Company Summary

Overview
Vimian Group is a provider of animal health services. It specializes in proprietary diagnostics, prescription and non-prescription treatments, procurement, tech-driven operations applications, etc. The company also offers molecular and immunodiagnostic solutions.
Type
Public
Status
Active
Founded
2021
HQ
Stockholm, SE | view all locations
Website
https://vimian.com/
Cybersecurity rating
Sectors

LocationsView all

1 location detected

  • Stockholm, Stockholms län HQ

    Sweden

    Riddargatan 19

Vimian Group Financials

Summary Financials

Revenue (Q1, 2026)
€116.0M
Gross profit (Q1, 2026)
€82.2M
Net income (Q1, 2026)
€10.1M
Cash (Q1, 2026)
€50.4M
EBIT (Q1, 2026)
€18.7M
Enterprise value
$23.9B

Footer menu